BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15040828)

  • 21. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy.
    Madeddu G; Spanu A; Chessa F; Calia GM; Lovigu C; Mannazzu M; Falchi A; Sanna D; Mura MS; Madeddu G
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):290-301. PubMed ID: 18596668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoporosis in patients on long-term home parenteral nutrition: a longitudinal study.
    Cohen-Solal M; Baudoin C; Joly F; Vahedi K; D'Aoust L; De Vernejoul MC; Messing B
    J Bone Miner Res; 2003 Nov; 18(11):1989-94. PubMed ID: 14606511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of long-term highly active antiretroviral therapy on bone mineral density in HIV/AIDS patients].
    Su YB; Xie J; Han Y; Qiu ZF; Li YL; Song XJ; Yu W; Li TS
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1155-8. PubMed ID: 22883000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of bone mineral density in Iranian HIV/AIDS patients.
    Badie BM; Soori T; Kheirandish P; Izadyar S; SeyedAlinagh S; Foroughi M; Rostamian A; Mohraz M
    Acta Med Iran; 2011; 49(7):460-7. PubMed ID: 21960080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
    Guo FP; Yu XB; Luo L; Han Y; Qiu ZF; Zuo LY; Li YL; Yu W; Li TS
    Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):649-52. PubMed ID: 20979781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with low bone mineral density in a Brazilian cohort of vertically HIV-infected adolescents.
    Schtscherbyna A; Pinheiro MF; Mendonça LM; Gouveia C; Luiz RR; Machado ES; Farias ML
    Int J Infect Dis; 2012 Dec; 16(12):e872-8. PubMed ID: 23031418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.
    Madeddu G; Spanu A; Solinas P; Babudieri S; Calia GM; Lovigu C; Mannazzu M; Nuvoli S; Piras B; Bagella P; Mura MS; Madeddu G
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4576-89. PubMed ID: 26698255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term use of protease inhibitors is associated with bone mineral density loss.
    Kinai E; Nishijima T; Mizushima D; Watanabe K; Aoki T; Honda H; Yazaki H; Genka I; Tanuma J; Teruya K; Tsukada K; Gatanaga H; Kikuchi Y; Oka S
    AIDS Res Hum Retroviruses; 2014 Jun; 30(6):553-9. PubMed ID: 24494779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
    Brown TT; Ruppe MD; Kassner R; Kumar P; Kehoe T; Dobs AS; Timpone J
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1200-6. PubMed ID: 15001610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy.
    Huang JS; Rietschel P; Hadigan CM; Rosenthal DI; Grinspoon S
    AIDS; 2001 May; 15(8):975-82. PubMed ID: 11399979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
    Mazzotta E; Ursini T; Agostinone A; Di Nicola AD; Polilli E; Sozio F; Vadini F; Pieri A; Trave F; De Francesco V; Capasso L; Borderi M; Manzoli L; Viale P; Parruti G
    AIDS Patient Care STDS; 2015 Apr; 29(4):169-80. PubMed ID: 25692868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
    Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low bone mineral density, regardless of HIV status, in men who have sex with men.
    Grijsen ML; Vrouenraets SM; Wit FW; Stolte IG; Prins M; Lips P; Reiss P; Prins JM
    J Infect Dis; 2013 Feb; 207(3):386-91. PubMed ID: 23148289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture.
    Pepe J; Isidori AM; Falciano M; Iaiani G; Salotti A; Diacinti D; Del Fiacco R; Sbardella E; Cipriani C; Piemonte S; Romagnoli E; Lenzi A; Minisola S
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):672-8. PubMed ID: 22630782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis.
    Bolland MJ; Grey AB; Gamble GD; Reid IR
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4522-8. PubMed ID: 17925333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy.
    Mora S; Sala N; Bricalli D; Zuin G; Chiumello G; Viganò A
    AIDS; 2001 Sep; 15(14):1823-9. PubMed ID: 11579244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study.
    Bonnet E; Ruidavets JB; Genoux A; Mabile L; Busato F; Obadia M; Prévoteau F; Marchou B; Massip P; Marion-Latard F; Delpierre C; Bernard J; Perret B
    BMC Infect Dis; 2013 Jun; 13():293. PubMed ID: 23809140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
    Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Prasitsuebsai W; Sophonphan J; Sohn AH; Ananworanich J; Puthanakit T;
    HIV Med; 2017 Apr; 18(4):235-244. PubMed ID: 27477214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone turnover markers in HIV disease.
    Haskelberg H; Carr A; Emery S
    AIDS Rev; 2011; 13(4):240-50. PubMed ID: 21975360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.